Teleflex (TFX) EBITDA Margin (2009 - 2026)
Teleflex's (TFX) quarterly EBITDA Margin came in at 12.77% in Q2 2026, down 783.0% on a YoY basis from 1.87% in Q2 2025, and up 246.86% quarter-over-quarter from 3.68% in Q1 2026.
Powered by 
Analysis
Teleflex (TFX) EBITDA Margin (2009 - 2026) Analysis & Trends
Teleflex (TFX) has reported EBITDA Margin for 18 consecutive years, with 12.77% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EBITDA Margin fell 783.0% year-over-year to 12.77%; the trailing twelve-month figure through Jun 2026 stood at 1.97% (down 1492.0% YoY), and the FY2025 full-year result was 5.94%, down 16.0% from the prior year.
- EBITDA Margin improved to 12.77% in Q2 2026 per TFX's latest filing, from 3.68% in the prior quarter.
- Across five years, EBITDA Margin topped out at 33.83% in Q4 2023 and bottomed at 17.39% in Q1 2024.
- Historically, EBITDA Margin has averaged 12.96% across 5 years, with a median of 16.53% in 2023.
- The sharpest annual moves came in 2024 and 2025: EBITDA Margin tumbled 3356 bps in 2024, then jumped 3568 bps in 2025.
- Over 5 years, EBITDA Margin stood at 16.96% in 2022, then surged by 99 bps to 33.83% in 2023, then slumped by 65 bps to 11.86% in 2024, then slumped by 79 bps to 2.44% in 2025, then surged by 424 bps to 12.77% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 12.77%, 3.68%, and 2.44% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.08 Bn | 174.48 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.86 Bn | 122.64 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.82 Bn | 100.34 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.95 Bn | 31.49 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 19.15% |
| 10 | Teleflex | 5.73 Bn | 5.43 Bn | 331.71 Mn | 12.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.77% |
| Mar 31, 2026 | 3.68% |
| Dec 31, 2025 | 2.44% |
| Sep 28, 2025 | -11.01% |
| Jun 29, 2025 | 20.59% |
| Mar 30, 2025 | 18.30% |
| Dec 31, 2024 | 11.86% |
| Sep 29, 2024 | 16.88% |
| Jun 30, 2024 | 12.20% |
| Mar 31, 2024 | -17.39% |
| Dec 31, 2023 | 33.83% |
| Oct 1, 2023 | 22.15% |
| Jul 2, 2023 | 19.32% |
| Apr 2, 2023 | 16.17% |
| Dec 31, 2022 | 16.96% |
| Sep 25, 2022 | 19.28% |
| Jun 26, 2022 | 19.18% |
| Mar 27, 2022 | 16.13% |
| Dec 31, 2021 | 20.35% |
| Sep 26, 2021 | 34.41% |